Stem cell mobilization offers new hope for uterine scarring and infertility
NCT ID NCT05343572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called plerixafor to see if it can help the body release its own bone marrow stem cells to repair the uterus. It is for women with Asherman's syndrome, a thin uterine lining, or repeated IVF failure. The goal is to thicken the uterine lining and improve pregnancy chances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASHERMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale Fertility Center
RECRUITINGOrange, Connecticut, 06477, United States